The information on this page was last updated on 19 May 2022.

The Company’s shares are only traded on the London Stock Exchange’s AIM market at present.

The number of shares in issue is 187,228,802 ordinary shares of 10p each. No ordinary shares are held as treasury shares and therefore the total number of voting rights in the Company is 187,228,802.

There are no restrictions on the transfer of securities.

As far as the Company is aware, the percentage of the Company’s issued share capital not in public hands (as defined by the AIM Rules for Companies) is 22.06%.

In so far as the Company has been notified, the Company’s significant (3% or larger) shareholders are as follows.

Name

Number of shares

% of total ISC

Richard Sneller

20,059,500

10.71%

Stonehage Fleming Investment Management Ltd

19,883,699

10.62%

Columbia Threadneedle Investments

11,532,834

6.16%

Premier Milton Group plc

8,529,969

4.56%

Liontrust Investment Partners LLP

8,968,584

4.46%

David & Monique Newlands

7,216,900

3.85%

Unicorn Asset Management Limited

5,759,291

3.08%

 

Directors’ shareholdings

Name

Number of shares

% of total ISC

Mr Robert Holt OBE (Chairman)

1,399,810

0.75%

Mr Mike Rogers, Non-Executive Director

260,000

0.14%

Mr Tony Bourne, Non-Executive Director

161,000

0.09%

Mrs Wendy Lawrence, Chief Executive Officer

148,123

0.08%

Mrs Lisa Barter, Finance Director

133,000

0.07%

Mrs Gloria Cooke, Clinical Quality Director

50,500

0.03%

 

For all shareholder enquiries please contact John Charlton, Group Company Secretary, at john.charlton@totallyplc.com